ABCD criteria to improve visual inspection with acetic acid (VIA) triage in HPV-positive women: a prospective study of diagnostic accuracy
Patrick Petignat, Bruno Kenfack, Ania Wisniak, Essia Saiji, Jean-Christophe Tille, Jovanny Tsuala Fouogue, Rosa Catarino, Eveline Tincho, Pierre Vassilakos, Patrick Petignat, Bruno Kenfack, Ania Wisniak, Essia Saiji, Jean-Christophe Tille, Jovanny Tsuala Fouogue, Rosa Catarino, Eveline Tincho, Pierre Vassilakos
Abstract
Objectives: A simple system for visual inspection with acetic acid assessment, named ABCD criteria, has been developed to increase accuracy for triaging of high-risk human papillomavirus (HPV)-positive women. This study aimed to determine the accuracy of ABCD criteria for the detection of histologically confirmed cervical intraepithelial neoplasia grade two or worse (CIN2+) in HPV-positive women living in a low-resource setting.
Design: Prospective study of diagnostic accuracy.
Setting: Cervical cancer screening programme based on a 3T-Approach (test, triage and treat) in the Health District of Dschang, West Cameroon.
Participants: Asymptomatic non-pregnant women aged 30-49 years were eligible to participate. Exclusion criteria included history of CIN treatment, anogenital cancer or hysterectomy. A total of 1980 women were recruited (median age, 40 years; IQR 35-45 years), of whom 361 (18.4%) were HPV-positive and 340 (94.2%) completed the trial.
Interventions: HPV-positive women underwent a pelvic examination for visual assessment of the cervix according to ABCD criteria. The criteria comprised A for acetowhiteness, B for bleeding, C for colouring and D for diameter. The ABCD criteria results were codified as positive or negative and compared with histological analysis findings (reference standards).
Primary outcome measure: Diagnostic performance of ABCD criteria for CIN2+, defined as sensitivity, specificity, negative and positive predictive values.
Results: ABCD criteria had a sensitivity of 77.5% (95% CI 61.3% to 88.2%), specificity of 42.0% (95% CI 36.5% to 47.7%), positive predictive value of 15.1% (95% CI 10.8% to 20.8%), and negative predictive value of 93.3% (95% CI 87.6% to 96.5%) for detection of CIN2 +lesions. Most (86.7%) of the ABCD-positive women were treated on the same day.
Conclusions: ABCD criteria can be used in the context of a single-visit approach and may be the preferred triage method for management of HPV-positive women in a low-income context.
Trial registration number: NCT03757299.
Keywords: community gynaecology; education & training (see medical education & training); gynaecological oncology; preventive medicine; public health.
Conflict of interest statement
Competing interests: None declared.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Figures
References
- GLOBOCAN 2020. Global Cancer Observatory. International Agency for Research on Cancer [online]. Available: [Accessed 16 Nov 2021].
- Ronco G, Dillner J, Elfström KM, et al. . Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2014;383:524–32. 10.1016/S0140-6736(13)62218-7
- World Health Organization . WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition [online]. Geneva, Switzerland. Available: [Accessed 1 Nov 2021].
- Sauvaget C, Fayette J-M, Muwonge R, et al. . Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet 2011;113:14–24. 10.1016/j.ijgo.2010.10.012
- World Health Organization . Cervical cancer elimination initiative [online]. Available: [Accessed 9 Nov 2021].
- Tebeu P-M, Fokom-Domgue J, Crofts V, et al. . Effectiveness of a two-stage strategy with HPV testing followed by visual inspection with acetic acid for cervical cancer screening in a low-income setting. Int J Cancer 2015;136:E743–50. 10.1002/ijc.29250
- Untiet S, Vassilakos P, McCarey C, et al. . HPV self-sampling as primary screening test in sub-Saharan Africa: implication for a triaging strategy. Int J Cancer 2014;135:1911–7. 10.1002/ijc.28834
- Sankaranarayanan R, Nene BM, Shastri SS, et al. . HPV screening for cervical cancer in rural India. N Engl J Med 2009;360:1385–94. 10.1056/NEJMoa0808516
- Denny L, Kuhn L, De Souza M, et al. . Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 2005;294:2173–81. 10.1001/jama.294.17.2173
- Bigoni J, Gundar M, Tebeu P-M, et al. . Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women. Int J Cancer 2015;137:127–34. 10.1002/ijc.29353
- Lim JNW, Ojo AA. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review. Eur J Cancer Care 2017;26:12444. 10.1111/ecc.12444
- Levy J, de Preux M, Kenfack B, et al. . Implementing the 3T-approach for cervical cancer screening in Cameroon: preliminary results on program performance. Cancer Med 2020;9:7293–300. 10.1002/cam4.3355
- Internation Agency for Research on Cancer . A practical manual on visual screening for cervical neoplasia. IARC Technical Publication Sankaranarayanan R, Wesley RS. 41st edn, 2003.
- Poli UR, Gowrishankar S, Swain M, et al. . Triage of women testing positive with the careHPV test on self-collected vaginal samples for cervical cancer screening in a low-resource setting. J Glob Oncol 2018;4:1–7. 10.1200/JGO.2016.008078
- Toliman PJ, Kaldor JM, Badman SG, et al. . Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea. Papillomavirus Res 2018;6:70–6. 10.1016/j.pvr.2018.10.009
- Sherigar B, Dalal A, Durdi G, et al. . Cervical cancer screening by visual inspection with acetic acid--interobserver variability between nurse and physician. Asian Pac J Cancer Prev 2010;11:619–22.
- Manga S, Parham G, Benjamin N, et al. . Cervical cancer screening in Cameroon: interobserver agreement on the interpretation of digital cervicography results. J Low Genit Tract Dis 2015;19:288–94. 10.1097/LGT.0000000000000133
- Dareng EO, Olaniyan Y, Odutola MK, et al. . Secular trend in interobserver agreement of VIA diagnosis for cervical cancer screening in Nigeria. PLoS One 2018;13:e0208531. 10.1371/journal.pone.0208531
- Catarino R, Vassilakos P, Scaringella S, et al. . Smartphone use for cervical cancer screening in low-resource countries: a pilot study conducted in Madagascar. PLoS One 2015;10:e0134309. 10.1371/journal.pone.0134309
- Tran PL, Benski C, Viviano M, et al. . Performance of smartphone-based digital images for cervical cancer screening in a low-resource context. Int J Technol Assess Health Care 2018;34:337–42. 10.1017/S0266462318000260
- Grohar D, Vassilakos P, Benkortbi K, et al. . Scaling up community-based cervical cancer screening in Cameroon employing a single visit approach. Int J Gynecol Cancer 2020;30:1455–7. 10.1136/ijgc-2020-001422
- Reid R, Stanhope CR, Herschman BR, et al. . Genital warts and cervical cancer. IV. A colposcopic index for differentiating subclinical papillomaviral infection from cervical intraepithelial neoplasia. Am J Obstet Gynecol 1984;149:815–23. 10.1016/0002-9378(84)90597-0
- Strander B, Ellström-Andersson A, Franzén S, et al. . The performance of a new scoring system for colposcopy in detecting high-grade dysplasia in the uterine cervix. Acta Obstet Gynecol Scand 2005;84:1013–7. 10.1111/j.0001-6349.2005.00895.x
- Sankaranarayanan R, Wesley R, Thara S, et al. . Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer 2003;106:404–8. 10.1002/ijc.11245
- Wesley R, Sankaranarayanan R, Mathew B, et al. . Evaluation of visual inspection as a screening test for cervical cancer. Br J Cancer 1997;75:436–40. 10.1038/bjc.1997.72
- Basu P, Sankaranarayanan R, Mandal R, et al. . Evaluation of downstaging in the detection of cervical neoplasia in Kolkata, India. Int J Cancer 2002;100:92–6. 10.1002/ijc.10445
- Kunckler M, Schumacher F, Kenfack B, et al. . Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach. Cancer Med 2017;6:1752–61. 10.1002/cam4.1089
- Goldhaber-Fiebert JD, Denny LE, De Souza M, et al. . The costs of reducing loss to follow-up in South African cervical cancer screening. Cost Eff Resour Alloc 2005;3:11. 10.1186/1478-7547-3-11
- Mutyaba T, Mirembe F, Sandin S, et al. . Male partner involvement in reducing loss to follow-up after cervical cancer screening in Uganda. Int J Gynaecol Obstet 2009;107:103–6. 10.1016/j.ijgo.2009.07.019
- Pinder LF, Parham GP, Basu P, et al. . Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol 2020;21:175–84. 10.1016/S1470-2045(19)30635-7
Source: PubMed